Information  X 
Enter a valid email address

Antisoma plc (SRC)

  Print      Mail a friend       Annual reports

Monday 04 August, 2008

Antisoma plc

Total Voting Rights

04 August 2008 London, UK: Antisoma plc  (LSE: ASM; USOTC: ATSMY)
notifies the market that the Company's issued share capital consists
of 613,565,378 ordinary shares with voting rights. Antisoma does not
hold any ordinary shares in Treasury.

Therefore, the total number of voting rights in Antisoma is

The above figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, Antisoma
under the FSA's Disclosure and Transparency Rules.

Daniel Elger, Director of Communications
Antisoma plc
+44 (0)20 3249 2100

Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company
that develops novel products for the treatment of cancer. The Company
has operations in the UK and the US. Please visit
for further information about Antisoma.